四氢-1-(4-哌啶基)-2(1h)-嘧啶酮 | 61220-36-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 四氢-1-(4-哌啶基)-2(1h)-嘧啶酮
• 英文名称: 1-(piperidin-4-yl)tetrahydropyrimidmn-2(1H)-one
• 英文别名: 4-(1,3-Propylenureido)-piperidin；4-<1,3-Propylenureido>-piperidin；4-(tetrahydro-2-oxo-1(2H)-pyrimidinyl)piperidine；1-(piperidin-4-yl)tetrahydropyrimidin-2(1H)-one；1-piperidinyl-4-yltetrahydropyrimidin-2[lH]-one；1-(piperidin-4-yl)tetrahydropyrimidin-2-one；1-(4-piperidyl)-2-oxo-hexahydro-pyrimidine；4-(2-oxoperhydropyrimidine-1-yl)piperidine；4-(2-oxoperhydropyrimidin-1-yl)piperidine；1-(4-piperidyl)-2-hexahydropyrimidinone；1-piperidin-4-yl-1,3-diazinan-2-one
• CAS: 61220-36-8
• 化学式: C₉H₁₇N₃O
• mdl: MFCD16066341
• 分子量: 183.253
• InChiKey: WQEZNOIZYDJGLE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.888
• 拓扑面积：
  44.4
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  [[P-(2-甲氧基乙基)苯氧基]甲基]环氧乙烷 、 四氢-1-(4-哌啶基)-2(1h)-嘧啶酮 在 ethyl acetate petroleum ether 作用下， 以 乙醇 为溶剂， 以to yield the 1-[3-(p-(2-methoxyethyl)-phenoxy)-2-hydroxypropyl]4-(2-oxo-hexahydro-1-pyrimidinyl)-piperidine, which melts at 113°-115° C.的产率得到1-(1-{2-hydroxy-3-[4-(2-methoxy-ethyl)-phenoxy]-propyl}-piperidin-4-yl)-tetrahydro-pyrimidin-2-one
  参考文献：
  名称：

  1-Substituted-4-(2-oxo-hexahydro-1-pyrimidinyl)-piperidine

  摘要：

  式子为##STR1##的哌啶衍生物，其中R.sub.1代表可选取代芳基，R.sub.2代表氢，低碳基，低烯基，酰基或.alpha.-芳基-低碳基，R.sub.3代表自由或取代羟基，alk代表低碳亚基，其将两个氮原子分离2或3个碳原子，R.sub.4代表氢或低碳基，n代表1到4的整数，以及它们的盐以及制造它们的过程和包含这些化合物的制药组合物，以及通过将这样的组合物用于温血动物宿主来降低血压的过程。

  公开号：

  US04075208A1
• 作为产物：
  描述：

  benzyl 4-(2-oxotetrahydropyrimidin-1(2H)-yl)piperidine-1-carboxylate 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙醇 为溶剂， 50.0 ℃ 、4.0 MPa 条件下， 以99%的产率得到四氢-1-(4-哌啶基)-2(1h)-嘧啶酮
  参考文献：
  名称：

  [EN] BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR AGONISTS
  [FR] COMPOSÉS AZA BICYCLIQUES EN TANT QU'AGONISTES DU RÉCEPTEUR MUSCARINIQUE M1.

  摘要：

  公开号：

  WO2015118342A8

文献信息

• N-Oxacyclic-alkylpiperidines as psychostimulants
  申请人：Ciba-Geigy Corporation

  公开号：US04329348A1

  公开（公告）日：1982-05-11

  N-Oxacyclic-alkylpiperidyl-diazacompounds, e.g., those of the formula ##STR1## and salts thereof are antidepressants and psychostimulants.

  N-Oxacyclic-alkylpiperidyl-diazacompounds，例如，具有以下结构式##STR1##的化合物及其盐是抗抑郁药和精神刺激剂。
• 1-Substituted-4-(2-oxo-1-imidazolidinyl) piperidines
  申请人：Ciba-Geigy Corporation

  公开号：US03956335A1

  公开（公告）日：1976-05-11

  Piperidines of the formula ##SPC1## In which R.sub.1 stands for optionally substituted aryl, R.sub.2 for hydrogen, lower alkyl, lower alkenyl, acyl or .alpha.-aryl-lower alkyl, R.sub.3 for a free or substituted hydroxyl group, alk for lower alkylene which separates the two nitrogen atoms by 2 or 3 carbon atoms, R.sub.4 represents hydrogen or lower alkyl and n represents an integer from 1 to 4, and their salts as well as processes for their manufacture and pharmaceutical compositions comprising such compounds, and a process for lowering the blood pressure wherein such compositions are administered to a warm-blooded host.

  式##SPC1##中的哌啶，其中R.sub.1代表可选择取代的芳基，R.sub.2代表氢、较低的烷基、较低的烯基、酰基或α-芳基-较低的烷基，R.sub.3代表自由或取代的羟基，alk代表通过2或3个碳原子分隔两个氮原子的较低的烷基，R.sub.4代表氢或较低的烷基，n代表从1到4的整数，以及它们的盐以及制造这些化合物的方法和包括这种化合物的制药组合物，以及一种降低血压的方法，其中将这种组合物给温血动物宿主。
• Cyclic amide derivatives for treating asthma
  申请人：Zeneca Limited

  公开号：US05589489A1

  公开（公告）日：1996-12-31

  Compounds of formula I ##STR1## wherein Q.sup.1, Q.sup.2, Q.sup.3, and Q.sup.4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of neurokinin A and useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.

  式I的化合物##STR1##其中Q.sup.1、Q.sup.2、Q.sup.3和Q.sup.4具有规范中给定的任意含义，它们的N-氧化物以及它们的药用盐是神经激肽A的非肽拮抗剂，可用于治疗哮喘等。还公开了制药组合物、制备式I化合物和中间体的方法。
• N-substituted naphthalene carboxamides as neurokinin-receptor antagonists
  申请人：Astra Zeneca AB

  公开号：US06365602B1

  公开（公告）日：2002-04-02

  A compound of formula I wherein: R is alkyl; R1 is optionally substituted phenyl 2-oxo-tetrahydro-1(2H)-pyrimidinyl, or 2-oxo-1-piperidinyl; R2 is hydrogen, alkoxy, alkanoyloxy, alkoxycarbonyl, alkanoylamino, acyl, alkyl, carbamoyl, N-alkylcarbamoyl, N,N-dialkylcarbamoyl where the alkyl groups are the same or different, hydroxy, thioacyl, thiocarbamoyl, N-alkylthiocarbamoyl, or N,N-dialkylthiocarbamoyl where the alkyl groups are the same or different. X1 and X2 are independently hydrogen or halo, provided that at least one of X1 or X2 is halo; and R3, R4, R5 and R6 are independently hydrogen, cyano, nitro, trifluoromethoxy, trifluoromethyl, or alkylsulfonyl are antagonists of at least one tachykinin receptor and are useful in the treatment of depression, anxiety, asthma, pain, inflammation, urinary incontinence and other disease conditions. Process for their preparation are described, as are compositions containing them and their use.

  公式I的化合物中：R是烷基；R1是可选择地取代的苯基2-氧代四氢-1(2H)-嘧啶基，或2-氧代-1-哌啶基；R2是氢、烷氧基、烷酰氧基、烷氧羰基、烷酰胺基、酰基、烷基、氨基甲酰基、N-烷基氨基甲酰基、N,N-二烷基氨基甲酰基（其中烷基基团相同或不同）、羟基、硫代酰基、硫代氨基甲酰基、N-烷基硫代氨基甲酰基、或N,N-二烷基硫代氨基甲酰基（其中烷基基团相同或不同）。X1和X2独立地为氢或卤素，但至少X1或X2中的一个为卤素；R3、R4、R5和R6独立地为氢、氰基、硝基、三氟甲氧基、三氟甲基、或烷基磺酰基，它们是至少一种催吐肽受体的拮抗剂，对治疗抑郁症、焦虑症、哮喘、疼痛、炎症、尿失禁和其他疾病情况有用。描述了它们的制备方法，以及含有它们和它们的用途的组合物。
• [EN] CYCLIC AMIDE DERIVATIVES, AND THEIR PRODUCTION AND USE AS ANTITHROMBOTIC AGENTS<br/>[FR] DÉRIVÉS D'AMIDES CYCLIQUES ET LEUR PRODUCTION ET UTILISATION COMME AGENTS ANTITHROMBOTIQUES
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2005113504A1

  公开（公告）日：2005-12-01

  The present invention provides a cyclic amide derivative useful as a drug for treating thrombosis, which is represented by the formula (I): wherein R1 represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent chain hydrocarbon group, a represents 0, 1, or 2, X1 represents an optionally substituted lower alkylene or an optionally substituted lower alkenylene, Y1 represents -C(O)-, -S(O)- or -S(O)2-, A represents a piperazine ring which may be further substituted or a piperidine ring which may be further substituted, X2 represents a bond or an optionally substituted lower alkylene, Y2 represents -C(O)-, -S(O)-, -S(O)2- or -C(=NR7)-, X3 represents an optionally substituted C1-4 alkylene or an optionally substituted C2-4 alkenylene, Z3 represents -N(R4)-, -O- or a bond, Z1 represents -C(R2)(R2')-, -N(R2)-, etc., and Z2 represents -C(R3)(R3')-, -N(R3)-, etc., or a salt thereof.

  本发明提供了一种环酰胺衍生物，可用作治疗血栓症的药物，其化学式为（I）：其中R1代表一个可选择取代的环烃基或一个可选择取代的杂环基，W代表一个键或一个可选择取代的双价链烃基，a代表0、1或2，X1代表一个可选择取代的较低碳烷基或一个可选择取代的较低烯烃基，Y1代表-C（O）-、-S（O）-或-S（O）2-，A代表可能进一步取代的哌嗪环或可能进一步取代的哌啶环，X2代表一个键或一个可选择取代的较低碳烷基，Y2代表-C（O）-、-S（O）-、-S（O）2-或-C（=NR7）-，X3代表一个可选择取代的C1-4烷基或一个可选择取代的C2-4烯烃基，Z3代表-N（R4）-、-O-或一个键，Z1代表-C（R2）（R2'）-、-N（R2）-等，Z2代表-C（R3）（R3'）-、-N（R3）-等，或其盐。